AGENTS OF CHANGE – TSG CATALYST

AGENTS OF CHANGE


Conundrums are our thing.
Show us your business problems –
we live to solve them.

Problem

Our client was late to market and needed to differentiate from current leaders

SOLUTION

CATALYST related subtle difference in MOA to highlight meaningful differences in clinical profile.

Contact Us

Problem

Our client needed to tell a story with limited clinical data

SOLUTION

CATALYST created a reason to believe, independent of clinical data based on basic science.

Contact Us

Problem

Our client had multiple indications that needed to resonate with different specialists

SOLUTION

CATALYST positioned the drug to focus on common unmet patient needs across the two indications.

Contact Us

Problem

Our client was behind in their launch readiness timeline

SOLUTION

CATALYST aligned the best talent to task and scaled up the team to deliver 1 year’s worth of market development work in 6 months.

Contact Us

Problem

Our client was launching into an area with limited perceived unmet need

SOLUTION

CATALYST focused on disease awareness using cutting-edge technology to help HCPs better appreciate the burden of disease and to generate empathy as a trigger for behavioral change.

Contact Us

Problem

Our client was launching into a rapidly changing marketplace

SOLUTION

CATALYST created platform to aggregate both internal and competitor data in real time, allowing the team to adjust messages, strategies, and tactics in order to stay ahead of the market.

Contact Us

Problem

Our client’s product was late in its life cycle with limited new data on the horizon

SOLUTION

CATALYST used unbranded disease education to redefine the problem and pathology of the disease for low-prescribing HCPs and to better align with the MOA of the drug.

Contact Us

Problem

Our client had limited reach to specialists

SOLUTION

CATALYST launched an on-demand peer-to-peer education platform to generate sales rep access to highly restricted offices.

Contact Us

Problem

Our client was introducing a new paradigm with the launch of the first biosimilar drug in a therapeutic area

SOLUTION

CATALYST simplified the complex regulatory pathway for biosimilars, while reassuring HCPs of the scientific rigor required for their approval. We successfully translated the science of biosimilarity into an understanding of predictable safety and efficacy.

Contact Us

Problem

Our client had limited advocacy for their brand

SOLUTION

CATALYST reengaged an alienated specialty audience, partnering with them to generate a patient-centric education curriculum, demonstrating a commitment to improving patient outcomes.

Contact Us

Problem

Our client’s product was for a rare disease

SOLUTION

CATALYST leveraged EMR technologies to improve the identification of a rare disease, resulting in earlier diagnosis and improved patient outcomes.

Contact Us